Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-18 Sale |
2020-09-22 8:02 pm |
Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer |
5,000 | $99.98 | $499,918 | 131,196 (Indirect Direct) |
View |
| 2020-08-18 Sale |
2020-08-20 8:17 pm |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $100 | $1,500,000 | 169,883 (Direct) |
View |
| 2020-08-18 Sale |
2020-08-20 8:01 pm |
Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer |
7,500 | $99.37 | $745,240 | 63,823 (Indirect Direct) |
View |
| 2020-08-10 Sale |
2020-08-12 8:01 pm |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
6,000 | $88.61 | $531,665 | 44,699 (Direct) |
View |
| 2020-07-15 Sale |
2020-07-17 8:01 pm |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $80.07 | $1,201,070 | 184,883 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-02 8:48 pm |
Principia Biopharma Inc. | PRNB | Colowick Alan Director |
7,500 | $60 | $450,000 | 47,724 (Direct) |
View |
| 2020-06-23 Sale |
2020-06-25 8:07 pm |
Principia Biopharma Inc. | PRNB | Babler Martin President, CEO |
15,000 | $61.86 | $927,889 | 144,072 (Indirect Direct) |
View |
| 2020-06-15 Sale |
2020-06-17 9:52 pm |
Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer |
5,504 | $60.75 | $334,385 | 19,096 (Direct) |
View |
| 2020-06-12 Sale |
2020-06-15 8:12 pm |
Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer |
5,000 | $61.16 | $305,788 | 122,435 (Indirect Direct) |
View |
| 2020-05-19 Sale |
2020-05-21 8:01 pm |
Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer |
7,500 | $65.1 | $488,268 | 71,323 (Indirect Direct) |
View |
| 2020-05-07 Sale |
2020-05-08 8:05 pm |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
6,000 | $60.16 | $360,941 | 33,415 (Direct) |
View |
| 2020-05-01 Sale |
2020-05-05 8:07 pm |
Principia Biopharma Inc. | PRNB | Colowick Alan Director |
7,500 | $60.01 | $450,057 | 117,108 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-09-28 Equity Swap |
2020-09-28 5:27 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | George Simeon Director |
2,982,855 | $100 | 0 (Indirect) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:24 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director |
667,600 | $100 | 0 (Indirect) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:19 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer |
13,592 | $100 | 0 (Direct) |
View |
| 2020-09-18 Gift |
2020-09-28 5:19 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer |
5,504 | $0 | 0 (Direct) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:16 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
2,207 | $100 | 0 (Direct) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:14 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer |
119,677 | $100 | 0 (Direct) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:11 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer |
7,101 | $100 | 0 (Direct) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:08 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
31,826 | $100 | 0 (Direct) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:07 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin President, CEO |
58,557 | $100 | 0 (Direct) |
View |
| 2020-09-18 Exercise |
2020-09-22 8:02 pm |
N/A 2025-02-25 |
Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer |
5,000 | $0 | 131,196 (Direct) |
View |
| 2020-09-18 Exercise |
2020-09-22 8:02 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer |
2,242 | $7.2671 | 131,196 (Direct) |
View |
| 2020-09-18 Exercise |
2020-09-22 8:02 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer |
2,758 | $4.7236 | 131,196 (Direct) |
View |
| 2020-08-18 Exercise |
2020-08-20 8:17 pm |
N/A 2028-10-22 |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $0 | 169,883 (Direct) |
View |
| 2020-08-18 Exercise |
2020-08-20 8:17 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $23.77 | 169,883 (Direct) |
View |
| 2020-08-18 Exercise |
2020-08-20 8:01 pm |
N/A 2023-12-11 |
Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer |
7,500 | $0 | 63,823 (Direct) |
View |
| 2020-08-18 Exercise |
2020-08-20 8:01 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer |
7,500 | $2.9977 | 63,823 (Direct) |
View |
Ownership |
2020-08-20 4:19 pm |
N/A 2020-11-20 |
Principia Biopharma Inc. | PRNB | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
0 | $0 | 4,893,400 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 8:01 pm |
N/A 2023-10-23 |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
6,000 | $0 | 44,699 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 8:01 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
2,447 | $2.9977 | 44,699 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 8:01 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
3,553 | $3.1794 | 44,699 (Direct) |
View |
| 2020-07-15 Exercise |
2020-07-17 8:01 pm |
N/A 2028-10-22 |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $0 | 184,883 (Direct) |
View |
| 2020-07-15 Exercise |
2020-07-17 8:01 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer |
15,000 | $23.77 | 184,883 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-02 8:48 pm |
N/A 2027-06-26 |
Principia Biopharma Inc. | PRNB | Colowick Alan Director |
7,500 | $0 | 47,724 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-02 8:48 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Colowick Alan Director |
7,500 | $4.542 | 47,724 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-25 8:07 pm |
N/A 2023-10-23 |
Principia Biopharma Inc. | PRNB | Babler Martin President, CEO |
15,000 | $0 | 144,072 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-25 8:07 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin President, CEO |
15,000 | $2.9977 | 144,072 (Direct) |
View |
| 2020-06-12 Exercise |
2020-06-15 8:12 pm |
N/A 2025-02-25 |
Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer |
5,000 | $0 | 122,435 (Direct) |
View |
| 2020-06-12 Exercise |
2020-06-15 8:12 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer |
5,000 | $4.7236 | 122,435 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 8:12 pm |
N/A 2030-06-03 |
Principia Biopharma Inc. | PRNB | Tomasello Shawn Director |
10,240 | $0 | 10,240 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 8:10 pm |
N/A 2030-06-03 |
Principia Biopharma Inc. | PRNB | Machado Patrick Director |
10,240 | $0 | 10,240 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 8:08 pm |
N/A 2030-06-03 |
Principia Biopharma Inc. | PRNB | George Simeon Director |
10,240 | $0 | 10,240 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 8:05 pm |
N/A 2030-06-03 |
Principia Biopharma Inc. | PRNB | Lin Shao-Lee Director |
10,240 | $0 | 10,240 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 8:03 pm |
N/A 2030-06-03 |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director |
10,240 | $0 | 10,240 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 8:02 pm |
N/A 2030-06-03 |
Principia Biopharma Inc. | PRNB | Colowick Alan Director |
10,240 | $0 | 10,240 (Direct) |
View |
| 2020-05-19 Exercise |
2020-05-21 8:01 pm |
N/A 2023-12-11 |
Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer |
5,675 | $0 | 71,323 (Direct) |
View |
| 2020-05-19 Exercise |
2020-05-21 8:01 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer |
5,675 | $2.9977 | 71,323 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-08 8:05 pm |
N/A 2023-10-23 |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
6,000 | $0 | 33,415 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-08 8:05 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
6,000 | $2.9977 | 33,415 (Direct) |
View |
| 2020-05-01 Exercise |
2020-05-05 8:07 pm |
N/A 2027-06-26 |
Principia Biopharma Inc. | PRNB | Colowick Alan Director |
7,500 | $0 | 117,108 (Direct) |
View |
| 2020-05-01 Exercise |
2020-05-05 8:07 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Colowick Alan Director |
7,500 | $4.542 | 117,108 (Direct) |
View |